Coronary vasodilatation produced by dopamine after adrenergic blockade.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects* / Q000502:physiology; D004106:Dilatation; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology*; D018492:Dopamine Antagonists; D004336:Drug Antagonism; D006220:Haloperidol / Q000494:pharmacology*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007545:Isoproterenol / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005996:Nitroglycerin / Q000494:pharmacology*; D010477:Perfusion; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology*; D011941:Receptors, Adrenergic; D012039:Regional Blood Flow; D014309:Tripelennamine / Q000494:pharmacology; D014628:Vagotomy; D014665:Vasodilator Agents / Q000494:pharmacology; D016276:Ventricular Function
D018492:Dopamine Antagonists; D006584:Hexamethonium Compounds; D011941:Receptors, Adrenergic; D014665:Vasodilator Agents; D014309:Tripelennamine; D011433:Propranolol; D005996:Nitroglycerin; D006220:Haloperidol; D007545:Isoproterenol; D004298:Dopamine; D010646:Phentolamine